{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:16:40Z","timestamp":1793038600000,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.amjms.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:40:33Z","timestamp":1536118833000},"page":"424-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases\u2014Clostridium difficile Disease and Beyond"],"prefix":"10.1016","volume":"356","author":[{"given":"Joshua","family":"Stripling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.amjmed.2014.02.017","article-title":"Fecal microbiota transplantation in the treatment of Clostridium difficile infections","volume":"127","author":"Austin","year":"2014","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.amjms.2018.08.010_bib0002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.08.010_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12879-016-1610-3","article-title":"Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach","volume":"16","author":"Desai","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jama.2014.17103","article-title":"Diagnosis and treatment of Clostridium difficile in adults: a systematic review","volume":"313","author":"Bagdasarian","year":"2015","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.amjms.2018.08.010_bib0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0007","doi-asserted-by":"crossref","first-page":"ofx144","DOI":"10.1093\/ofid\/ofx144","article-title":"The intestinal microbiome in infectious diseases: the clinical relevance of a rapidly emerging field","volume":"4","author":"Harris","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11739-014-1069-4","article-title":"Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?","volume":"9","author":"Cammarota","year":"2014","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/mi.2010.79","article-title":"Therapeutic transplantation of the distal gut microbiota","volume":"4","author":"Khoruts","year":"2011","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/M16-2810","article-title":"Methods and reporting studies assessing fecal microbiota transplantation: a systematic review","volume":"167","author":"Bafeta","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on fecal microbiota transplantation 2015: Indications, methodologies, mechanisms, and outlook","volume":"149","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.amjms.2018.08.010_bib0012","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M14-2693","article-title":"Fecal microbiota transplantation for Clostridium difficile infection: a systematic review","volume":"162","author":"Drekonja","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0013","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjms.2018.08.010_bib0014","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.amjms.2018.08.010_bib0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.amjms.2018.08.010_bib0016","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/M16-0271","article-title":"Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial","volume":"165","author":"Kelly","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0017","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cid\/ciw731","article-title":"Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent clostridium difficile infection: an open-label, randomized controlled trial","volume":"64","author":"Hota","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0018","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.amjms.2018.08.010_bib0019","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCG.0b013e318234570b","article-title":"Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results","volume":"46","author":"Kelly","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MCG.0000000000000374","article-title":"Long-term follow-up study of fecal microbiota transplantation for severe and\/or complicated Clostridium difficile infection: a multicenter experience","volume":"50","author":"Aroniadis","year":"2016","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0022","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Kassam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.amjms.2018.08.010_bib0023","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s10096-014-2088-9","article-title":"The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema","volume":"33","author":"Lee","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0024","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s15010-012-0307-9","article-title":"Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis","volume":"40","author":"Postigo","year":"2012","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jhin.2017.05.004","article-title":"Comparative effectiveness of faecal microbiota transplant by route of administration","volume":"96","author":"Gundacker","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.amjms.2018.08.010_bib0026","doi-asserted-by":"crossref","unstructured":"Osman M, Kelsey O'brien, Zachery Stoltzner, et al. Safety and efficacy of fecal microbiota transplantation for recurrent Clostridium difficile infection from an international public stool bank: results from a 2,050 patient multi-center cohort Paper presented at: IDWeek2016; New Orleans, LA.","DOI":"10.1093\/ofid\/ofw172.1668"},{"issue":"17","key":"10.1016\/j.amjms.2018.08.010_bib0027","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.2014.13875","article-title":"Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection","volume":"312","author":"Youngster","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjms.2018.08.010_bib0028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12879-015-0930-z","article-title":"Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection","volume":"15","author":"Hirsch","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0029","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ajg.2017.6","article-title":"Successful resolution of recurrent Clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study","volume":"112","author":"Staley","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.amjms.2018.08.010_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002503","article-title":"Fecal transplants: what is being transferred","volume":"14","author":"Bojanova","year":"2016","journal-title":"PLoS Biol"},{"issue":"12","key":"10.1016\/j.amjms.2018.08.010_bib0032","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0033","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/JCM.02327-16","article-title":"Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"55","author":"Woodworth","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0034","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0035","doi-asserted-by":"crossref","first-page":"e00322","DOI":"10.1128\/mBio.00322-16","article-title":"Transfer of viral communities between human individuals during fecal microbiota transplantation","volume":"7","author":"Chehoud","year":"2016","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.amjms.2018.08.010_bib0036","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/MIB.0000000000000405","article-title":"Donor recruitment for fecal microbiota transplantation","volume":"21","author":"Paramsothy","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.amjms.2018.08.010_bib0037","article-title":"Systematic review: adverse events of fecal microbiota transplantation","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhin.2015.10.024","article-title":"Adverse events in faecal microbiota transplant: a review of the literature","volume":"92","author":"Baxter","year":"2016","journal-title":"J Hosp Infect"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0039","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2017.01.028","article-title":"The AGA's fecal microbiota transplantation national registry: an important step toward understanding risks and benefits of microbiota therapeutics","volume":"152","author":"Kelly","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.amjms.2018.08.010_bib0040","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis","volume":"58","author":"Konijeti","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149521","article-title":"Cost-effectiveness analysis of six strategies to treat recurrent Clostridium difficile infection","volume":"11","author":"Lapointe-Shaw","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170258","article-title":"Cost-effectiveness analysis of five competing strategies for the management of multiple recurrent community-onset Clostridium difficile infection in France","volume":"12","author":"Baro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2018.08.010_bib0043","doi-asserted-by":"crossref","unstructured":"Walker JMD, Gundacker, N, Rodriguez, M, et al. Cost effectiveness analysis of fecal transplant delivery methods for recurrent Clostridium difficile Infections in Outpatients Paper presented at: IDWeek2017; San Diego, CA.","DOI":"10.1093\/ofid\/ofx163.960"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0044","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/ice.2014.80","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"36","author":"Varier","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.amjms.2018.08.010_bib0045","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"10","key":"10.1016\/j.amjms.2018.08.010_bib0046","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","article-title":"Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis","volume":"23","author":"Narula","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171308","article-title":"Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial","volume":"12","author":"Tian","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0048","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nmo.12479","article-title":"Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?","volume":"27","author":"Pinn","year":"2015","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0049","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5056\/jnm16074","article-title":"Serial frozen fecal microbiota transplantation in the treatment of chronic intestinal pseudo-obstruction: a preliminary study","volume":"23","author":"Gu","year":"2017","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.amjms.2018.08.010_bib0052","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/913867","article-title":"Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up","volume":"2014","author":"Satokari","year":"2014","journal-title":"Case Rep Med"},{"issue":"7","key":"10.1016\/j.amjms.2018.08.010_bib0053","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3748\/wjg.v23.i7.1319","article-title":"Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis","volume":"23","author":"Gunaltay","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0054","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal microbiota transplantation in metabolic syndrome: history, present and future","volume":"8","author":"de Groot","year":"2017","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0056","first-page":"383","article-title":"Treating obesity and metabolic syndrome with fecal microbiota transplantation","volume":"89","author":"Marotz","year":"2016","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0057","doi-asserted-by":"crossref","first-page":"ofv004","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0058","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","article-title":"Therapeutic potential of fecal microbiota transplantation","volume":"145","author":"Smits","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0059","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5946\/ce.2015.117","article-title":"Fecal microbiota transplantation: current applications, effectiveness, and future perspectives","volume":"49","author":"Choi","year":"2016","journal-title":"Clin Endosc"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","article-title":"Fecal microbiota transplantation broadening its application beyond intestinal disorders","volume":"21","author":"Xu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2018.08.010_bib0061","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12916-016-0604-8","article-title":"Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?","volume":"14","author":"Forsythe","year":"2016","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.amjms.2018.08.010_bib0062","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1124\/dmd.115.063826","article-title":"Microbiome disturbances and autism spectrum disorders","volume":"43","author":"Rosenfeld","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0063","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0064","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5946\/ce.2016.098","article-title":"Fecal microbiota transplantation and the brain microbiota in neurological diseases","volume":"49","author":"Ruggiero","year":"2016","journal-title":"Clin Endosc"},{"issue":"9","key":"10.1016\/j.amjms.2018.08.010_bib0065","first-page":"1452","article-title":"The evidence for microbiome manipulation in inflammatory arthritis","volume":"56","author":"Jethwa","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.amjms.2018.08.010_bib0066","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s12272-016-0796-7","article-title":"Gut microbiota in autoimmunity: potential for clinical applications","volume":"39","author":"Kim","year":"2016","journal-title":"Arch Pharmacal Res"},{"issue":"3","key":"10.1016\/j.amjms.2018.08.010_bib0067","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000443357","article-title":"The gastrointestinal tract microbiota and allergic diseases","volume":"34","author":"Kyburz","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.amjms.2018.08.010_bib0068","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrrheum.2016.68","article-title":"The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions","volume":"12","author":"Abdollahi-Roodsaz","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.amjms.2018.08.010_bib0069","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13054-016-1491-2","article-title":"Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis","volume":"20","author":"Wei","year":"2016","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.amjms.2018.08.010_bib0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/civ938","article-title":"Safety and durability of RBX2660 (Microbiota Suspension) for recurrent clostridium difficile infection: results of the PUNCH CD study","volume":"62","author":"Orenstein","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjms.2018.08.010_bib0071","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1053\/j.gastro.2014.01.004","article-title":"From stool transplants to next-generation microbiota therapeutics","volume":"146","author":"Petrof","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.amjms.2018.08.010_bib0072","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/jiv766","article-title":"A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection","volume":"214","author":"Khanna","year":"2016","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.amjms.2018.08.010_bib0073","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.2015.3725","article-title":"Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial","volume":"313","author":"Gerding","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjms.2018.08.010_bib0074","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918303380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918303380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T16:35:37Z","timestamp":1661963737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918303380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0002962918303380"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.08.010","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases\u2014Clostridium difficile Disease and Beyond","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}